These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 28530267
21. Effect of lanthanide complex structure on cell viability and association. Peterson KL, Dang JV, Weitz EA, Lewandowski C, Pierre VC. Inorg Chem; 2014 Jun 16; 53(12):6013-21. PubMed ID: 24901440 [Abstract] [Full Text] [Related]
22. A time-resolved luminescence biosensor assay for anaplastic lymphoma kinase (ALK) activity. Cui W, Parker LL. Chem Commun (Camb); 2015 Jun 16; 51(2):362-5. PubMed ID: 25406835 [Abstract] [Full Text] [Related]
23. Development of a terbium complex-based luminescent probe for imaging endogenous hydrogen peroxide generation in plant tissues. Ye Z, Chen J, Wang G, Yuan J. Anal Chem; 2011 Jun 01; 83(11):4163-9. PubMed ID: 21548628 [Abstract] [Full Text] [Related]
24. Fluorescent and lanthanide labeling for ligand screens, assays, and imaging. Josan JS, De Silva CR, Yoo B, Lynch RM, Pagel MD, Vagner J, Hruby VJ. Methods Mol Biol; 2011 Jun 01; 716():89-126. PubMed ID: 21318902 [Abstract] [Full Text] [Related]
25. Sequence selective dual-emission detection of (i, i + 1) bis-phosphorylated peptide using diazastilbene-type Zn(II)-Dpa chemosensor. Ishida Y, Inoue MA, Inoue T, Ojida A, Hamachi I. Chem Commun (Camb); 2009 May 28; (20):2848-50. PubMed ID: 19436886 [Abstract] [Full Text] [Related]
26. Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft. Raub TJ, Wishart GN, Kulanthaivel P, Staton BA, Ajamie RT, Sawada GA, Gelbert LM, Shannon HE, Sanchez-Martinez C, De Dios A. Drug Metab Dispos; 2015 Sep 28; 43(9):1360-71. PubMed ID: 26149830 [Abstract] [Full Text] [Related]
27. First bodipy-DOTA derivatives as probes for bimodal imaging. Bernhard C, Goze C, Rousselin Y, Denat F. Chem Commun (Camb); 2010 Nov 21; 46(43):8267-9. PubMed ID: 20877903 [Abstract] [Full Text] [Related]
28. A highly luminescent and highly oxygen-sensitive Tb(III) complex with a tris-aryloxide functionalised 1,4,7-triazacyclononane ligand. Nakai H, Goto T, Kitagawa K, Nonaka K, Matsumoto T, Ogo S. Chem Commun (Camb); 2014 Dec 25; 50(99):15737-9. PubMed ID: 25364794 [Abstract] [Full Text] [Related]
29. Cell cycle inhibitors make progress. Brower V. J Natl Cancer Inst; 2014 Jul 25; 106(7):. PubMed ID: 25006194 [No Abstract] [Full Text] [Related]
30. CDK4/6 blockade in breast cancer: current experience and future perspectives. Zardavas D, Pondé N, Tryfonidis K. Expert Opin Investig Drugs; 2017 Dec 25; 26(12):1357-1372. PubMed ID: 29027483 [Abstract] [Full Text] [Related]
31. Time-resolved probes and oxidase-based biosensors using terbium(III)-guanosine monophosphate-mercury(II) coordination polymer nanoparticles. Zhang M, Qu ZB, Han CM, Lu LF, Li YY, Zhou T, Shi G. Chem Commun (Camb); 2014 Nov 04; 50(85):12855-8. PubMed ID: 25208485 [Abstract] [Full Text] [Related]
32. Inhibition of cyclin-dependent kinases 4 and 6 in breast cancer. Mayer EL. Clin Adv Hematol Oncol; 2015 Apr 04; 13(4):215-7. PubMed ID: 26352578 [No Abstract] [Full Text] [Related]
39. A luminescent affinity tag for proteins based on the terbium(III)-binding peptide. Sueda S, Tanaka S, Inoue S, Komatsu H. Anal Biochem; 2012 Mar 01; 422(1):52-4. PubMed ID: 22266297 [Abstract] [Full Text] [Related]